Total amount: € 0,00
HOW TO ORDER
THE JOURNAL OF CARDIOVASCULAR SURGERY
A Journal on Cardiac, Vascular and Thoracic Surgery
Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,632
ORIGINAL ARTICLES VASCULAR SECTION
The Journal of Cardiovascular Surgery 2013 June;54(3):359-65
Excimer laser atherectomy after unsuccessful angioplasty of TASC C and D lesions in femoropopliteal arteries
Wissgott C., Kamusella P., Lüdtke C., Andresen R. ✉
Institute of Diagnostic and , Interventional Radiology/Neuroradiology, Westküstenklinikum Heide, Academic Teaching Hospital of the Universities of , Kiel, Lübeck and Hamburg, Heide, Germany
Aim: The study objective was to examine the application of excimer laser atherectomy (ELA) in patients with refractory occlusions in femoropopliteal arteries, where the initial conventional percutaneous transluminal angioplasty (PTA) recanalization attempts, were unsuccessful.
Methods: The average age of the 40 patients (32 men, 8 women) included in this study was 65.4±9.1 years. The average occlusion length was 17.5 cm (range: 12-25 cm). The initial recanalization attempts were performed with stiff Terumo guidewires (curved or straight) supported by various catheters (straight/multipurpose/Cobra). After the unsuccessful attempt, an excimer laser catheter (catheter diameters from 1.7-2.5 mm) was used for recanalization using the step-by-step method of crossing. After successful crossing, balloon dilatation was performed in all cases. Stent implant was required in 10% (4/40) of procedures. Patients were followed for 12 months with colour-coded Duplex sonography (CCDS).
Results: The initial technical success rate of 90% (36/40) resulted in primary, primary-assisted and secondary-assisted patency rates of 58.9%, 67.8% and 83.2%, respectively, after 12 months. No serious complications occurred that were attributable to the intervention.
Conclusion: According to these results, ELA recanalization provides a low stent rate alternative to surgical procedures for refractory occlusions. This would offer patients, with increased operative risks, a promising and low-risk therapeutic procedure. The option of a subsequent vascular operation would not be compromised.